Topical tacrolimus and Crohn disease.
Hodgson
T
T
Hegarty
A
A
Porter
S
S
D000042:Absorption; D000287:Administration, Topical; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009061:Mouth Mucosa / Q000378:metabolism; D016559:Tacrolimus / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016559:Tacrolimus